Biogen (BIIB) EV to EBIT (2009 - 2023)
Biogen's EV to EBIT was 42.61 in Q2 2023, up 377.4% from 8.92 a year earlier and up 81.1% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EV to EBIT (2009 - 2023) Analysis & Trends
On a trailing twelve-month basis, Biogen's EV to EBIT was 24.62 through Jun 30, 2023, up 378.9% year-over-year; for FY2022, it came in at 26.63, up 139.9% from FY2021.
- EV to EBIT has now increased for three consecutive years.
- In earlier years, EV to EBIT was 11.10 in FY2021 (+45.6%), 7.62 in FY2020 (+13.7%), 6.70 in FY2019 (-29.3%) and 9.48 in FY2018 (-20.5%).
- The Q2 2023 figure marks the highest quarterly EV to EBIT in data going back to Q1 2009.
- Compared with a year earlier, EV to EBIT has increased for three straight quarters, with growth averaging 88.9% over the last eight quarters.
- The best year-over-year quarter for EV to EBIT over five years was Q2 2023 (growth of 377.4%); the worst was Q2 2022 (a decline of 59.7%).
- Per Business Quant data, BIIB's EV to EBIT in the three quarters before Q2 2023 was 23.53 (Q1 2023), 15.01 (Q4 2022) and 11.62 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 42.61 |
| Mar 31, 2023 | 23.53 |
| Dec 31, 2022 | 15.01 |
| Sep 30, 2022 | 11.62 |
| Jun 30, 2022 | 8.92 |
| Mar 31, 2022 | 10.93 |
| Dec 31, 2021 | 11.10 |
| Sep 30, 2021 | 20.32 |
| Jun 30, 2021 | 22.13 |
| Mar 31, 2021 | 10.68 |
| Dec 31, 2020 | 7.62 |
| Sep 30, 2020 | 6.02 |
| Jun 30, 2020 | 5.15 |
| Mar 31, 2020 | 6.49 |
| Dec 31, 2019 | 6.70 |
| Sep 30, 2019 | 5.60 |
| Jun 30, 2019 | 6.09 |
| Mar 31, 2019 | 7.16 |
| Dec 31, 2018 | 9.48 |
| Sep 30, 2018 | 11.29 |
API Access
Biogen EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();